While you are here...
A unique insight into the development of BioInnovation Institute
We proudly present our Impact Report for 2021, which presents data and stories from BioInnovation Institute (BII). In the report, you can find information about how we work and our approach to fulfilling our mission of bringing ideas to life and research to market. It showcases how BII has continued and progressed in establishing key partnerships with industrial companies, universities and venture capital funds. Furthermore, it confirms that BII as a commercial foundation with a non-profit objective plays a crucial role in helping early-stage companies to turn pioneering science into a range of therapeutic, health tech and bioindustrial applications with significant societal impact.
We want to take the occasion and say a huge thank you to all our partners, stakeholders and the whole ecosystem since all of you have contributed immensely to the positive development that BII experienced in 2021.
“2021 was our first year as a commercial foundation with a non-profit objective. During the year, BII has launched many new initiatives to make an impact for people and society, and the many start-up companies in BII’s community within life science and biotechnology are growing at a fast pace.
BII has awarded grants and loans to high-growth start-up companies at a total of more than DKK 400 million (EUR 56.3 million), and the companies have in 2021 already raised more than DKK 1 billion (EUR 145.5) in external funding.
The life science innovation ecosystem is thriving and has never been stronger, as stated in the recent report about the Danish Life Science Ecosystem. At the same time, there is an urgent need for solutions to many of the significant societal challenges. There is therefore still much to be done, and it is only through entrepreneurship that science is translated to commercially sustainable and successful solutions benefitting people and society.
To push for that development, we have broadened our outreach to attract the very best ideas and strengthened our programs to create the best learning environment. As a result, the BII brand is getting stronger and we experience more applications from other Nordic and European countries.
At BII, we celebrate the power of working together, also with external partners, collaborators and service providers. Partnerships and collaborations continue to be crucial components in the continued development and success of BII, and we are therefore thrilled that we can present two joint initiatives: one with the Bill & Melinda Gates Foundation: on raising awareness of the women’s health agenda internationally; and one with the scientific journal Science to support the BII innovation agenda in the form of an international science innovation prize.
I hope you will enjoy our 2021 Impact Report that will describe highlights and provide information about some of our programs and companies.
Chief Executive Officer, BII
Building a catalyst platform
We have tested, evaluated and shaped our programs to meet the needs from early acceleration to maturation towards series A investment.
Besides BII Venture Lab and BII Creation House, BII has set up BII Residence and transformed BII Faculty into Bio Studio to foster the start-ups of tomorrow.
Supporting our thriving portfolio
BII funding, business development support, lab-and-office infrastructure and global network have allowed our portfolio to thrive. The portfolio today is strong within every field and continues to attract larger investments including Series A.
Outreach, community & collaborations
We build partnerships and collaborations with companies, universities, hospitals, investors and experts. In 2021, we have added substantial collaborations with the objective of strengthening the life science ecosystem further.
Small, large, national and international collaborations all support the creation of a strong foundation and community for the years to come.